Skip to contentApplication 065478
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 125MG BASE | No | No |
| 002 | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 250MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
| 17478-741 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn, Inc. | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
| 17478-742 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | Akorn | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 30666 | ORIG | 2012-04-11 |